SCM
NARI

Soleus Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Soleus Capital Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-93,878
Closed -$3.87M – 110
2024
Q3 		$3.87M Sell
93,878
-314,495
-77% -$15.1M 0.3% 66
2024
Q2 		$19.7M Buy
408,373
+131,373
+47% +$5.82M 1.73% 19
2024
Q1 		$13.3M Buy
+277,000
New +$14.8M 0.99% 34
2023
Q2 		– Sell
-101,450
Closed -$6.26M – 111
2023
Q1 		$6.26M Sell
101,450
-123,100
-55% -$7.39M 0.65% 44
2022
Q4 		$14.3M Buy
224,550
+122,942
+121% +$8.91M 2.05% 17
2022
Q3 		$7.38M Buy
101,608
+29,310
+41% +$2.18M 1% 30
2022
Q2 		$4.92M Buy
+72,298
New +$5.2M 0.77% 39
2021
Q3 		– Sell
-6,150
Closed -$574K – 85
2021
Q2 		$574K Sell
6,150
-15,300
-71% -$1.48M 0.09% 63
2021
Q1 		$2.29M Buy
+21,450
New +$2.23M 0.41% 47
2020
Q3 		– Sell
-65,817
Closed -$3.19M – 76
2020
Q2 		$3.19M Buy
+65,817
New +$3.14M 1.82% 20

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Soleus Capital Management's NARI Position: Q4 2024 in Review

Soleus Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 93,878 shares — an estimated $3.87M sold.

Soleus Capital Management first reported a position in NARI in Q2 2020 and held it in 10 quarters. The position peaked at $19.7M in Q2 2024. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

  • Soleus Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Soleus Capital Management sold 93,878 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $3.87M.
  • Soleus Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Soleus Capital Management's Inari Medical, Inc. Common Stock position peaked at $19.7M in Q2 2024.
  • 258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Soleus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.